Changes in medical and non-medical cannabis use among United States adults before and during the COVID-19 pandemic
- PMID: 35130464
- PMCID: PMC9308664
- DOI: 10.1080/00952990.2021.2007257
Changes in medical and non-medical cannabis use among United States adults before and during the COVID-19 pandemic
Abstract
Background: During the SARS-CoV-2 pandemic, cannabis dispensaries in the United States (US) reported increased sales.Objectives: This study assessed changes in cannabis use before to during the pandemic; it was hypothesized that cannabis use increased during the pandemic.Methods: A US-based survey of adults assessed patterns of use before and during the pandemic. Participants recruited via social media from 8/2020 to 9/2020 self-reported medical and non-medical cannabis use. Use was categorized as ≤ monthly, weekly, and daily/almost daily; adjusted logistic regressions determined associations between cannabis use before the pandemic with change in frequency during the pandemic.Results: Of 1,886 respondents (63% male),1,113 reported non-medical and 603 medical use of cannabis. Those reporting ≤monthly non-medical use before the pandemic had higher odds of increasing use during the pandemic than those using weekly before the pandemic (AOR 3.2 [95% CI 2.2-4.5]). Those reporting ≤ monthly and daily medical cannabis use before the pandemic had higher odds of increasing use during the pandemic than those using weekly before the pandemic (AOR 2.3 [95% 1.3, 3.9]; AOR 2.4 [95% CI 1.2, 5.1] respectively).Conclusions: The most notable increases in cannabis use during the pandemic were among those who reported using cannabis least frequently before the pandemic (two to three times odds of increased use among ≤ monthly use compared to weekly). These findings have important implications for potential health consequences related to increased cannabis use both during and after the pandemic, even in populations thought to be protected by minimal use prior to the pandemic.
Keywords: COVID-19; Cannabis; SARS-CoV-2; cannabinoids.
Figures
![Figure 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9308664/bin/nihms-1807186-f0001.gif)
![Figure 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9308664/bin/nihms-1807186-f0002.gif)
Similar articles
-
Changes in self-reported cannabis use during the COVID-19 pandemic: a scoping review.BMC Public Health. 2023 Nov 1;23(1):2139. doi: 10.1186/s12889-023-17068-7. BMC Public Health. 2023. PMID: 37915021 Free PMC article. Review.
-
The COVID-19 cannabis health study: Results from an epidemiologic assessment of adults who use cannabis for medicinal reasons in the United States.J Addict Dis. 2021 Jan-Mar;39(1):26-36. doi: 10.1080/10550887.2020.1811455. Epub 2020 Sep 15. J Addict Dis. 2021. PMID: 32933383 Free PMC article.
-
Selective Changes in Medical Cannabis Use Early in the COVID-19 Pandemic: Findings from a Web-Based Sample of Adults in the United States.Cannabis Cannabinoid Res. 2023 Feb;8(1):174-183. doi: 10.1089/can.2021.0115. Epub 2022 Jan 24. Cannabis Cannabinoid Res. 2023. PMID: 35073161 Free PMC article.
-
Cannabis sales increases during COVID-19: Findings from Alaska, Colorado, Oregon, and Washington.Int J Drug Policy. 2021 Dec;98:103384. doi: 10.1016/j.drugpo.2021.103384. Epub 2021 Aug 4. Int J Drug Policy. 2021. PMID: 34364201 Free PMC article.
-
Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping review.J Neural Transm (Vienna). 2023 Jan;130(1):7-18. doi: 10.1007/s00702-022-02564-8. Epub 2022 Nov 8. J Neural Transm (Vienna). 2023. PMID: 36346483 Free PMC article. Review.
Cited by
-
Associations of U.S. state-level COVID-19 policies intensity with cannabis sharing behaviors in 2020.Harm Reduct J. 2024 Apr 16;21(1):82. doi: 10.1186/s12954-024-00987-y. Harm Reduct J. 2024. PMID: 38622670 Free PMC article.
-
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2024.Diabetes Care. 2024 Jan 1;47(Suppl 1):S77-S110. doi: 10.2337/dc24-S005. Diabetes Care. 2024. PMID: 38078584 Review.
-
Changes in self-reported cannabis use during the COVID-19 pandemic: a scoping review.BMC Public Health. 2023 Nov 1;23(1):2139. doi: 10.1186/s12889-023-17068-7. BMC Public Health. 2023. PMID: 37915021 Free PMC article. Review.
-
Cannabis Use and Sharing Practices Among Sexual Minority and Heterosexual Individuals During the COVID-19 Pandemic.LGBT Health. 2023 Oct;10(7):514-525. doi: 10.1089/lgbt.2022.0236. Epub 2023 May 26. LGBT Health. 2023. PMID: 37252794 Free PMC article.
-
Acute Toxicity and Pharmacokinetic Profile of an EU-GMP-Certified Cannabis sativa L. in Rodents.Pharmaceuticals (Basel). 2023 May 3;16(5):694. doi: 10.3390/ph16050694. Pharmaceuticals (Basel). 2023. PMID: 37242477 Free PMC article.
References
-
- Czeisler MÉ, Lane RI, Petrosky E, Wiley JF, Christensen A, Njai R, Weaver MD, Robbins R, Facer-Childs ER, Barger LK, et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic — United States, June 24 –30, 2020. MMWR Morb Mortal Wkly Rep. 2020. Aug 14;69:1049–57. . - PMC - PubMed
-
- Substance Abuse and Mental Health Services Administration. 2019 NSDUH detailed tables [Internet]. 2020. Sep [accessed 2020 Nov9]. https://www.samhsa.gov/data/report/2019-nsduh-detailed-tables.
-
- Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry [Internet]. 2020. Sep 14 [accessed 2020 Nov8]. http://www.nature.com/articles/s41380-020-00880-7. - PMC - PubMed
-
- Michigan Marijuana Regulatory Agency. Marijuana Regulatory Agency Statistical Report [Internet]. 2020. [accessed 2020 Nov10]. https://www.michigan.gov/mra/0,9306,7-386-93032-497635–,00.html.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous